Prognostic value of left atrial function in systemic light-chain amyloidosis: a cardiac magnetic resonance study

Dania Mohty(Centre Hospitalier Universitaire de Limoges), Arnaud Jaccard(Centre Hospitalier Universitaire de Limoges), Nicolas Varroud‐Vial(Centre Hospitalier Universitaire de Poitiers), Julien Magné, Cyrille Boulogne, Victor Aboyans(The Princess Grace Hospital), H. Ettaif, Thibaud Damy(Amyloidosis Foundation), Bahaa M. Fadel(King Faisal Specialist Hospital & Research Centre), Frank Bridoux(Université de Poitiers), S Martin
European Heart Journal - Cardiovascular Imaging
May 18, 2016
10.1093/ehjci/jew100
Cited by 44

Related Papers

Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
|The Lancet|2017|13.6k
2018 ESC/ESH Guidelines for the management of arterial hypertension
|European Heart Journal|2018|10.5k
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010
|The Lancet|2012|9k
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010
|The Lancet|2012|8.4k
Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016
|The Lancet|2017|5k